Erythromycin Intramammary Infusion
If you find any inaccurate information, please let us know by providing your feedback here
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
Erythromycin Intramammary Infusion is a solution of Erythromycin in a suitable vegetable oil vehicle. It contains one or more suitable preservatives. It contains not less than 90.0 percent and not more than 120.0 percent of the labeled amount of C37H67NO13
Packaging and storage-Preserve in single-dose disposable syringes that are well-closed containers.
Labeling-Label it to indicate that it is for veterinary use only.
USP REFERENCE STANDARDS (11)-
USP Erythromycin RS
Identification-Transfer a quantity of Intramammary Infusion, equivalent to about 5 mg of erythromycin, to a separator containing 50 mL of solvent hexane. Shake until dissolved. Extract with three separate 20-mL portions of methanol. Combine the methanol extracts in a beaker, and evaporate to dryness. Dissolve the residue in 2 mL of methanol (test solution). Proceed as directed in the Identification test under Erythromycin Delayed-Release Capsules, beginning with "Prepare a Standard solution of USP Erythromycin RS."
MINIMUM FILL (755): meets the requirements.
WATER DETERMINATION, Method / (921): not more than 1.0%, 20 mL of a mixture of toluene and methanol (7:3) being used in place of methanol in the titration vessel.
Assay-Transfer the contents of a syringe of Intramammary Infusion to a separator containing 50 mL of solvent hexane. Shake until dissolved. Wash with four separate 20-mL portions of a mixture of methanol and water (4:1). Combine the washings in a 100-mL volumetric flask, dilute with the methanol and water solution to volume, and mix. Proceed as directed for erythromycin under Antibiotics-Microbial Assays (81), using an accurately measured volume of this stock solution diluted quantitatively with Buffer B.3 to yield a Test Dilution having a concentration of erythromycin assumed to be equal to the median dose level of the Reference Standard.
